SEI Investments’s Ovid Therapeutics OVID Stock Holding History

SEI Investments’s Portfolio OVID Stock Details OVID Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$730K	Buy	+328,924	New	+$588K	﹤0.01%	2511
2023 Q1	–	Sell	-33,832	Closed	-$62.9K	–	2722
2022 Q4	$62.9K	Hold	33,832	–	–	﹤0.01%	2476
2022 Q3	$62K	Sell	33,832 -39,156	-54%	-$81.9K	﹤0.01%	2608
2022 Q2	$157K	Sell	72,988 -46,366	-39%	-$112K	﹤0.01%	2515
2022 Q1	$375K	Hold	119,354	–	–	﹤0.01%	2211
2021 Q4	$383K	Buy	119,354 +38,657	+48%	+$132K	﹤0.01%	2249
2021 Q3	$271K	Hold	80,697	–	–	﹤0.01%	2348
2021 Q2	$316K	Buy	+80,697	New	+$318K	﹤0.01%	2290
2018 Q3	–	Sell	-97	Closed	-$1K	–	3151
2018 Q2	$1K	Buy	+97	New	+$833	﹤0.01%	3497

Other funds holding OVID

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

ACM

ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

SVCM

Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

SEI Investments's OVID Position: Q1 2026 in Review

SEI Investments opened a new position in Ovid Therapeutics (OVID) in Q1 2026: 328,924 shares worth $730K. The stake represents ﹤0.01% of the portfolio and ranks #2511 among its holdings. This is a return to the name: SEI Investments previously reported a position in OVID as recently as Q4 2022.

SEI Investments first reported a position in OVID in Q2 2018 and has held it in 9 quarters since. 103 funds tracked by Wall St. Rank hold OVID as of Q1 2026.

SEI Investments held 328,924 shares of Ovid Therapeutics worth $730K as of Q1 2026.
Ovid Therapeutics was a new SEI Investments position in Q1 2026.
Ovid Therapeutics made up ﹤0.01% of SEI Investments's portfolio in Q1 2026, its #2511 holding.
SEI Investments first reported a position in Ovid Therapeutics in Q2 2018 and has held it in 9 quarters since.
103 funds tracked by Wall St. Rank held Ovid Therapeutics as of Q1 2026.

Based on SEI Investments's 13F filing for Q1 2026, filed 13 May 2026.